Pharmagreen Biotech (Pharmagreen Biotech) Accounts Payable & Accrued Expense : $1.62 Mil (As of Jun. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Pharmagreen Biotech Accounts Payable & Accrued Expense?

Pharmagreen Biotech's quarterly accounts payable & accrued expense increased from Dec. 2022 ($1.45 Mil) to Mar. 2023 ($1.53 Mil) and increased from Mar. 2023 ($1.53 Mil) to Jun. 2023 ($1.62 Mil).

Pharmagreen Biotech's annual accounts payable & accrued expense increased from Sep. 2020 ($1.05 Mil) to Sep. 2021 ($1.26 Mil) and increased from Sep. 2021 ($1.26 Mil) to Sep. 2022 ($1.37 Mil).

Pharmagreen Biotech Accounts Payable & Accrued Expense Historical Data

The historical data trend for Pharmagreen Biotech's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmagreen Biotech Accounts Payable & Accrued Expense Chart

Pharmagreen Biotech Annual Data

Trend

Apr08

Apr09

Sep18

Sep19

Sep20

Sep21

Sep22

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.91

1.33

1.05

1.26

1.37

Pharmagreen Biotech Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															1.38	1.37	1.45	1.53	1.62

Pharmagreen Biotech Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Pharmagreen Biotech (Pharmagreen Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmagreen Biotech Inc (OTCPK:PHBI) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

112 North Curry Street, Carson, NV, USA, 89703

Website

https://www.pharmagreen.ca

Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.